Discipline | Cardiology |
---|---|
Language | English |
Edited by | M.G. Hennerici |
Publication details | |
History | 1991–present |
Publisher | |
Frequency | 8/year |
2.974 (2016) | |
Standard abbreviations | |
ISO 4 | Cerebrovasc. Dis. |
Indexing | |
ISSN | 1015-9770 (print) 1421-9786 (web) |
OCLC no. | 22789090 |
Links | |
Cerebrovascular Diseases is a peer-reviewed medical journal covering the study of cerebrovascular diseases. It was established in 1991 by Michael G. Hennerici and Julien Bogousslavsky, and is published eight times per year by Karger Publishers. Hennerici is the journal's editor-in-chief. According to the Journal Citation Reports , the journal has a 2016 impact factor of 2.974. [1]
Vascular dementia is dementia caused by a series of strokes. Restricted blood flow due to strokes reduces oxygen and glucose delivery to the brain, causing cell injury and neurological deficits in the affected region. Subtypes of vascular dementia include subcortical vascular dementia, multi-infarct dementia, stroke-related dementia, and mixed dementia.
Cerebrovascular disease includes a variety of medical conditions that affect the blood vessels of the brain and the cerebral circulation. Arteries supplying oxygen and nutrients to the brain are often damaged or deformed in these disorders. The most common presentation of cerebrovascular disease is an ischemic stroke or mini-stroke and sometimes a hemorrhagic stroke. Hypertension is the most important contributing risk factor for stroke and cerebrovascular diseases as it can change the structure of blood vessels and result in atherosclerosis. Atherosclerosis narrows blood vessels in the brain, resulting in decreased cerebral perfusion. Other risk factors that contribute to stroke include smoking and diabetes. Narrowed cerebral arteries can lead to ischemic stroke, but continually elevated blood pressure can also cause tearing of vessels, leading to a hemorrhagic stroke.
Apoplexy refers to the rupture of an internal organ and the associated symptoms. Informally or metaphorically, the term apoplexy is associated with being furious, especially as "apoplectic". Historically, it described what is now known as a hemorrhagic stroke, involving a ruptured blood vessel in the brain; modern medicine typically specifies the anatomical location of the bleeding, such as cerebral, ovarian, or pituitary.
Frovatriptan, sold under the brand name Frova, is a triptan drug developed by Vernalis for the treatment of migraine headaches and for short term prevention of menstrual migraine. The product is licensed to Endo Pharmaceuticals in North America and Menarini in Europe.
Emerging Infectious Diseases (EID) is an open-access, peer-reviewed journal published by the Centers for Disease Control and Prevention (CDC). EID is a public domain journal and covers global instances of new and reemerging infectious diseases, putting greater emphasis on disease emergence, prevention, control, and elimination. According to Journal Citation Reports, the journal's 2022 impact factor is 11.8. The journal also has a 2023 Google Scholar h5-index score of 106, ranking it 2nd in the epidemiology category and 4th in the communicable diseases category.
Vascular disease is a class of diseases of the vessels of the circulatory system in the body, including blood vessels – the arteries and veins, and the lymphatic vessels. Vascular disease is a subgroup of cardiovascular disease. Disorders in this vast network of blood and lymph vessels can cause a range of health problems that can sometimes become severe, and fatal. Coronary heart disease for example, is the leading cause of death for men and women in the United States.
Sneddon's syndrome is a form of arteriopathy characterized by several symptoms, including:
Hashimoto's encephalopathy, also known as steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT), is a neurological condition characterized by encephalopathy, thyroid autoimmunity, and good clinical response to corticosteroids. It is associated with Hashimoto's thyroiditis, and was first described in 1966. It is sometimes referred to as a neuroendocrine disorder, although the condition's relationship to the endocrine system is widely disputed. It is recognized as a rare disease by the NIH Genetic and Rare Diseases Information Center.
Hypohidrosis is a medical condition in which a person exhibits diminished sweating in response to appropriate stimuli. In contrast with hyperhidrosis, which is a socially troubling yet often benign condition, the consequences of untreated hypohidrosis include hyperthermia, heat stroke and death. An extreme case of hypohidrosis in which there is a complete absence of sweating and the skin is dry is termed anhidrosis. The condition is also known as adiaphoresis, ischidrosis, oligidria, oligohidrosis and sweating deficiency.
Subcortical ischemic depression, also known as vascular depression, is a medical condition most commonly seen in older people with major depressive disorder. Subcortical ischemic depression refers to vascular depression specifically due to lesions and restricted blood flow, known as ischemia, in certain parts of the brain. However, the disorder is typically described as vascular depression in the literature.
Clinical Infectious Diseases is a peer-reviewed medical journal published by Oxford University Press covering research on the pathogenesis, clinical investigation, medical microbiology, diagnosis, immune mechanisms, and treatment of diseases caused by infectious agents. It includes articles on antimicrobial resistance, bioterrorism, emerging infections, food safety, hospital epidemiology, and HIV/AIDS. It also features highly focused brief reports, review articles, editorials, commentaries, and supplements. The journal is published on behalf of the Infectious Diseases Society of America. The editor-in-chief is infectious disease physician Paul Sax.
Ivan Atanassov Petrov, is a noted Bulgarian neurologist and head of the Clinic of Neurology at the Medical Institute of the Ministry of Internal Affairs in Sofia, Bulgaria, and holds an MD, and PhD.
Lubeluzole (Prosynap) is a drug which acts as an indirect NMDA antagonist. It inhibits the release of glutamate, inhibits nitric oxide synthesis, and blocks calcium and sodium gated ion channels. It has neuroprotective effects particularly in hypoxic conditions, and was developed for the treatment of stroke. Trials showed it to be safe, effective and well tolerated at low doses, but unfortunately higher doses produced the dangerous cardiac side effect of lengthening the QTc interval, which could potentially lead to heart failure, and so this meant that subsequent trials were limited to using only the low dose range. Animal studies had shown lubeluzole to produce neuroprotective effects when administered for prolonged periods, but the aim of its developers was to produce a drug that would be effective for preventing damage from acute stroke, and so ultimately it failed to show sufficient efficacy in trials and development for medical use was halted.
Terutroban is an antiplatelet agent developed by Servier Laboratories. It is a selective thromboxane prostanoid (TP) antagonist and is an orally active drug in clinical development for the secondary prevention of acute thrombotic complications.
A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain, tauopathies, and altered levels of consciousness. There are many recognized neurological disorders, some are relatively common, but many are rare.
Pankaj Sharma is a British professor of Clinical Neurology at Royal Holloway College, University of London, and consultant neurologist at Imperial College London. He is director of the Institute of Cardiovascular Research at Royal Holloway (ICR2UL), and formerly head of the Imperial College Cerebrovascular Research Unit (ICCRU) at Imperial College London. His main interest is in identifying genes for stroke, particularly in those of South Asian heritage.
The Journal of Pharmacy and Pharmacology is a monthly peer-reviewed scientific journal covering all aspects of pharmacy and pharmacology. It is published by Wiley-Blackwell on behalf of the Royal Pharmaceutical Society. It is an official journal of the British Pharmaceutical Conference. It was established in 1870 and acquired its current title in 1949. The editor-in-chief is D. Jones.
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease is a peer-reviewed open access scientific journal and an official journal of the American Heart Association. Since 2015, it is also published with John Wiley & Sons. It was established in 2012 and the editor-in-chief is Bruce Ovbiagele.
Raad Shakir CBE is Professor of Neurology at Imperial College London and a Consultant Neurologist at Charing Cross Hospital.
Jean-Claude Baron is an Emeritus Professor of Stroke Medicine at the University of Cambridge. He is also a Fellow of the Academy of Medical Sciences. He has authored around 450 peer-reviewed articles.